Sunil Healthcare Intrinsic Value
Sunil Healthcare intrinsic value. Sunil Healthcare (SUNLOC) median intrinsic value is ₹80.00 from 9 valuation models (range ₹20–₹170), vs current price ₹68.00 — +17.6% upside (Trading Below Median Value), margin of safety 15.0%. Compare with SUNLOC fair price to assess whether the stock is under or overvalued.
SUNLOC Valuation Methods Summary — DCF, Graham Number & P/E
Sunil Healthcare intrinsic value across 9 models vs current price ₹68.00 — upside/downside and value range per method. Read SUNLOC dividend growth for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹50.16 | ₹40.13 - ₹60.19 | -26.2% | EPS: ₹2.28, Sector P/E: 22x |
| Book Value Method | asset | ₹140.00 | ₹126.00 - ₹154.00 | +105.9% | Book Value/Share: ₹70.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹136.00 | ₹122.40 - ₹149.60 | +100.0% | Revenue/Share: ₹80.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹80.00 | ₹72.00 - ₹88.00 | +17.6% | EBITDA: ₹8.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹170.00 | ₹136.00 - ₹204.00 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹20.40 | ₹18.36 - ₹22.44 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹35.23 | ₹31.71 - ₹38.75 | -48.2% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹96.00 | ₹86.40 - ₹105.60 | +41.2% | ROE: 11.4%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹59.92 | ₹53.93 - ₹65.91 | -11.9% | EPS: ₹2.28, BVPS: ₹70.00 |
SUNLOC Intrinsic Value vs Market Price — All Valuation Models
Sunil Healthcare fair value range ₹20–₹170 vs current market price ₹68.00 across 9 valuation models. For current market price and key ratios, visit Sunil Healthcare share price chart.
SUNLOC Intrinsic Value Analysis — Undervalued or Overvalued?
Sunil Healthcare median intrinsic value ₹80.00, current price ₹68.00 — Trading Below Median Value by 17.6%, margin of safety 15.0%.
What is the intrinsic value of SUNLOC?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sunil Healthcare (SUNLOC) is ₹80.00 (median value). With the current market price of ₹68.00, this represents a +17.6% variance from our estimated fair value.
The valuation range spans from ₹20.40 to ₹170.00, indicating ₹20.40 - ₹170.00.
Is SUNLOC undervalued or overvalued?
Based on our multi-method analysis, Sunil Healthcare (SUNLOC) appears to be trading below median value by approximately 17.6%.
SUNLOC Financial Health — Key Ratios vs Industry Benchmarks
Sunil Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.55 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.4% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.48x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SUNLOC Cash Flow Quality — Operating & Free Cash Flow
Sunil Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹22 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹12 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-15 Cr | ₹-20 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹8 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹23 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |